Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

INTERCOVID-2022: The University of Oxford is to launch the 2022 round of the global study to evaluate the effects of Covid-19 variants and vaccination in pregnancy.

Newborn baby being placed onto mobile baby scales

Less than a year after three papers reporting the main results of the INTERCOVID Study were published in leading medical journals, the University of Oxford is this week launching the second round of the largest global study comparing Covid-19 in pregnancy with pregnant women without the infection. The updated aims of this large multinational effort are to: 1) Evaluate the effect of the new variants of the virus on pregnant women and newborns and 2) Quantify the effect of vaccination on the complications described during pregnancy and the neonatal period.

Despite the growing body of evidence regarding the dangers of Covid-19 during pregnancy – higher risk of maternal death, preeclampsia/eclampsia, severe infections, intensive care unit admissions, preterm births, and severe neonatal complications - and the efficacy and safety of Covid-19 vaccines during pregnancy, countries have been recording alarmingly low rates of vaccination amongst this high-risk group. Little is known, however, about the impact during pregnancy of new variants of the virus, such as Omicron. The researchers aim to fill that gap as quickly as possible because without large-scale, peer-reviewed research, the impact should not be underestimated.

Read the full story on the University of Oxford website

Similar stories

New research reveals relationship between particular brain circuits and different aspects of mental wellbeing

Researchers at the University of Oxford have uncovered previously unknown details about how changes in the brain contribute to changes in wellbeing.

Night-time blood pressure assessment is found to be important in diagnosing hypertension

Around 15% of people aged 40-75 may have a form of undiagnosed high blood pressure (hypertension) that occurs only at night-time. Because they do not know about this, and therefore are not being treated for it, they are at a higher risk of cardiovascular disease such as stroke, heart failure, and even death, suggests new research from the University of Oxford published in the British Journal of General Practice.

Major new NIHR Global Health Research Unit to focus on data science and genomic surveillance of antimicrobial resistance

The Centre for Genomic Pathogen Surveillance, part of the Big Data Institute at the University of Oxford, has been awarded funding worth £7m for their work as an NIHR Global Health Research Unit (GHRU) for the next five years. The Centre’s research and capacity building work focuses on delivering genomics and enabling data for the surveillance of antimicrobial resistance (AMR).

How artificial intelligence is shaping medical imaging

Dr Qiang Zhang of the Radcliffe Department of Medicine explains how artificial intelligence is being used to help researchers and physicians interpret medical imaging.

Researchers describe how cancer cells can defend themselves from the consequences of certain genetic defects

Researchers in Department of Physiology, Anatomy and Genetics have identified a rescue mechanism that allows cancers to overcome the consequences of inactivating mutations in critically important genes.